Stoke Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for STOK, updated each market day.
STOK AI Sentiment
AI sees no strong directional signal for Stoke Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Stoke Therapeutics, Inc. Common Stock
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Sector
Exchange
Market Cap
$2,079,150,268
Cap Tier
Employees
170
Headquarters
BEDFORD, MA
Listed Since
June 19, 2019
STOK Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
STOK Volatility
Stoke Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
